VectivBio Holding AG Analysis

VECTDelisted Stock  USD 16.85  0.00  0.00%   
VectivBio Holding AG is overvalued with Real Value of 12.53 and Hype Value of 16.85. The main objective of VectivBio Holding delisted stock analysis is to determine its intrinsic value, which is an estimate of what VectivBio Holding AG is worth, separate from its market price. There are two main types of VectivBio Holding's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect VectivBio Holding's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of VectivBio Holding's stock to identify patterns and trends that may indicate its future price movements.
The VectivBio Holding stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. VectivBio Holding is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. VectivBio Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and VectivBio Holding's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

VectivBio Stock Analysis Notes

About 84.0% of the company outstanding shares are owned by institutional investors. The book value of VectivBio Holding was at this time reported as 3.4. The company recorded a loss per share of 2.1. VectivBio Holding had not issued any dividends in recent years. VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. The company was incorporated in 2019 and is headquartered in Basel, Switzerland. VectivBio Holding is traded on NASDAQ Exchange in the United States. For more information please call Luca MD at 41 61 551 30 3 or visit https://vectivbio.com.

VectivBio Holding Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. VectivBio Holding's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding VectivBio Holding AG or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
VectivBio Holding is not yet fully synchronised with the market data
VectivBio Holding has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 27.34 M. Net Loss for the year was (93.73 M) with profit before overhead, payroll, taxes, and interest of 27.34 M.
VectivBio Holding AG currently holds about 142.14 M in cash with (56.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09.
Over 84.0% of the company outstanding shares are owned by institutional investors

VectivBio Holding Upcoming and Recent Events

Earnings reports are used by VectivBio Holding to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to VectivBio Holding previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
19th of July 2023
Upcoming Quarterly Report
View
31st of March 2023
Next Fiscal Quarter End
View
17th of April 2024
Next Fiscal Year End
View
31st of December 2022
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

VectivBio Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.06 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VectivBio Holding's market, we take the total number of its shares issued and multiply it by VectivBio Holding's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

VectivBio Holding Predictive Daily Indicators

VectivBio Holding intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of VectivBio Holding stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About VectivBio Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how VectivBio Holding prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling VectivBio shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as VectivBio Holding. By using and applying VectivBio Stock analysis, traders can create a robust methodology for identifying VectivBio entry and exit points for their positions.
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. The company was incorporated in 2019 and is headquartered in Basel, Switzerland. VectivBio Holding is traded on NASDAQ Exchange in the United States.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding VectivBio Holding to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the VectivBio Holding information on this page should be used as a complementary analysis to other VectivBio Holding's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in VectivBio Stock

If you are still planning to invest in VectivBio Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VectivBio Holding's history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum